BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23242476)

  • 1. Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
    Huang HC; Cheng AL; Lin CW; Kuo SH
    Ann Hematol; 2013 Jul; 92(7):989-92. PubMed ID: 23242476
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
    Papageorgiou SG; Diamantopoulos P; Levidou G; Angelopoulou MK; Economopoulou P; Efthimiou A; Constantinou N; Katsigiannis A; Korkolopoulou P; Pappa V; Economopoulou C; Georgiou G; Dimou M; Tsirigotis P; Kyrtsonis MC; Kotsianidis I; Kalpadakis C; Dimopoulos MA; Beris P; Meletis J; Pangalis GA; Dervenoulas J; Panayiotidis P; Vassilakopoulos TP
    Hematol Oncol; 2013 Mar; 31(1):10-7. PubMed ID: 22610484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma--a case report and review of literature.
    Senapati J; Devasia AJ; Sudhakar S; Viswabandya A
    Ann Hematol; 2014 Sep; 93(9):1599-602. PubMed ID: 24362455
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.
    Guirguis HR; Cheung MC; Mahrous M; Piliotis E; Berinstein N; Imrie KR; Zhang L; Buckstein R
    Br J Haematol; 2012 Oct; 159(1):39-49. PubMed ID: 22849793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy.
    Niscola P; Palombi M; Trawinska MM; Scaramucci L; Giovannini M; Perrotti AP; Fabritiis Pd; Fratoni S
    Oral Oncol; 2009 Sep; 45(9):e113. PubMed ID: 19457710
    [No Abstract]   [Full Text] [Related]  

  • 7. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual sites of involvement in non-Hodgkin's lymphoma: Case 2. Isolated meningeal anaplastic large-cell lymphoma.
    Aloulou S; Bosq J; Vanel D; Ribrag V
    J Clin Oncol; 2002 Nov; 20(21):4395-7. PubMed ID: 12409340
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary T cell leptomeningeal lymphoma--successful treatment with systemic chemotherapy.
    Yeh KH; Cheng AL; Tien HF
    Oncology; 1995; 52(6):501-4. PubMed ID: 7478439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
    Maruyama D
    Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
    Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of primary mucosa-associated lymphoid tissue lymphoma of the bladder regressed after rituximab in combination with CHOP chemotherapy].
    Kakuta Y; Katoh T; Saitoh J; Yazawa K; Hosomi M; Itoh K
    Hinyokika Kiyo; 2006 Dec; 52(12):951-4. PubMed ID: 17252980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Shimada K
    Brain Nerve; 2011 May; 63(5):467-72. PubMed ID: 21515926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
    Conrad AL; Go RS
    Eur J Haematol; 2009 Dec; 83(6):603-5. PubMed ID: 19682312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab CHOP for successful management of diffuse large B-cell lymphoma of the ovary.
    Ahbeddou N; Fetohi M; Khanoussi BE; Errihani H
    Arch Gynecol Obstet; 2011 May; 283(5):1173-4. PubMed ID: 20957380
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
    Fabbri A; Gozzetti A; Rigacci L
    Cancer; 2011 Aug; 117(15):3530; author reply 3531. PubMed ID: 21287541
    [No Abstract]   [Full Text] [Related]  

  • 19. First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial.
    Vitolo U; Chiappella A; Ferreri AJ; Martelli M; Baldi I; Balzarotti M; Bottelli C; Conconi A; Gomez H; Lopez-Guillermo A; Martinelli G; Merli F; Novero D; Orsucci L; Pavone V; Ricardi U; Storti S; Gospodarowicz MK; Cavalli F; Sarris AH; Zucca E
    J Clin Oncol; 2011 Jul; 29(20):2766-72. PubMed ID: 21646602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapericardial and intrapleural administration of rituximab to a patient with marginal zone lymphoma.
    Boguradzki P; Drozd-Sokolowska JE; Wieczorek J; Kowalik R; Starczewska M; Krol M; Kobylecka M; Opolski G; Wiktor-Jedrzejczak W
    Acta Haematol; 2013; 130(3):169-71. PubMed ID: 23735747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.